XEMBIFY is the first and only 20% subcutaneous immunoglobulin (SCIg) with FDA-approved dosing for treatment-naïve patients, enabling them to go straight to SCIg without initial intravenous therapy Approval, which also includes biweekly dosing, follows phase 4 study data demonstrating comparable total Ig levels when administering XEMBIFY every two weeks versus weekly The expanded label for […]
Category Archives: Pr Newswire
Pr Newswire
iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered Mammography
29
Jul
Jul
Windsong Radiology to Champion First Wave of ProFound AI Breast Health Suite Expansion NASHUA, N.H. and WILLIAMSVILLE, N.Y. and RALEIGH, N.C., July 29, 2024 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, today announced a strategic agreement with Windsong Radiology Group, one of US Radiology Specialists, […]
29
Jul
Jul
BOSTON, July 29, 2024 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, announced today that Lara S. Sullivan, M.D., President and Chief Executive Officer, and members of management will participate in one-on-one meetings at the BTIG Virtual Biotechnology Conference being held […]
Pr Newswire
MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers
29
Jul
Jul
Research Published in THE LANCET’s eClinicalMedicineEscharEx® Outperforms Non-Surgical Standard of Care in Debridement and Promotion of Healthy Granulation Tissue YAVNE, Israel, July 29, 2024 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair, today announces the peer-reviewed publication on the Phase II ChronEx study assessing the safety […]
Pr Newswire
Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis
29
Jul
Jul
– Co-primary endpoint of PASI 75 and sPGA 0/1 score at 24 weeks to serve as basis for U.S. regulatory submission – – Pivotal Phase 3 program supported by positive Phase 2 STRIDE clinical data as well as ongoing open-label extension (OLE) study – – Topline data anticipated in 2026 – SOUTH SAN FRANCISCO, Calif., […]
THE HOTEL HIGASHIYAMA KYOTO TOKYU, A Pan Pacific Hotel, will be added to group’s portfolio in Japan from 10 January 2025 SINGAPORE, July 29, 2024 /PRNewswire/ — Pan Pacific Hotels Group debuts in Kyoto with the signing of a strategic partnership with Tokyu Hotels following the launch of BELLUSTAR TOKYO, A Pan Pacific Hotel and HOTEL […]
GUANGZHOU, China, July 29, 2024 /PRNewswire/ — Xuan Wu Cloud Technology Holdings Limited (“Xuan Wu Cloud” or the “Group,” stock code: 2392.HK), a leading intelligent CRM service provider in China, today announced its positive alert for the six months ended June 30, 2024. Based on the information currently available to the Board and a preliminary […]
Revenue Reached RMB9,259 Million in the Second Quarter, Excluding COVID-19 Commercial Projects, Up 0.3% Year-over-Year Revenue Reached RMB17,241 Million for the First Half, Excluding COVID-19 Commercial Projects, Down 0.7% Year-over-Year Net Profit Attributable to the Owners of the Company Reached RMB4,240 Million, and Diluted Earnings per Share (EPS) of RMB1.45 for the First Half Adjusted Non-IFRS […]
UNLIMEAT’s Plant-Based Korean Meals Across 149 GIANT and MARTIN’S Stores. The product lineup includes plant-based meat and convenient meals like frozen kimbap products. NEW YORK, July 29, 2024 /PRNewswire/ — UNLIMEAT, a pioneering Korean plant-based food brand, has announced the launch of five products in 149 GIANT and MARTIN’S stores. UNLIMEAT’s K-Vegan Line at GIANT […]
Key Takeaways Wildfire smoke may be particularly hazardous to brain health, according to a 10-year study of more than 1.2 million southern Californians. Exposure to wildfire smoke increases the risk of being diagnosed with dementia more than other forms of air pollution. The risk of exposure to fine particulate matter (PM2.5) air pollution is much […]